Abstract
The craniofacial complex develops during the first trimester of pregnancy, but its final shaping, which is mainly dependent on genetic factors, extends into the second and third trimesters. It is intimately connected with the development of the brain because the numerous signals which control craniofacial development originate in the brain and vice versa. As a result, malformations of one organ may affect the development of the other. Craniofacial anomalies are either isolated, resulting from abnormal development of the first two embryonic pharyngeal arches, or part of multiple malformation syndromes affecting many other organs. They may stem from gene mutations, chromosomal aberrations, or environmental causes induced by teratogens. The craniofacial morphologic changes are not only cosmetic as they may often interfere with important functions such as chewing, swallowing, and respiration and/or cause hearing or visual impairment. We discussed only a small number of craniofacial malformations and their diagnosis and treatment. Following a brief description of the craniofacial development, we discussed oral clefts, craniofacial microsomia, and teratogens that may affect craniofacial development resulting in different malformations and the genetically determined craniosynostosis syndromes. The understanding of these malformations is important in medicine and in dentistry as the approach for diagnosis and treatment is generally multidisciplinary.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Creuzet SE, Martinez S, Le Douarin NM. The cephalic neural crest exerts a critical effect on forebrain and midbrain development. PNAS. 2006;103:14033–8.
Abramyan J, Richman JM. Craniofacial development: discoveries made in the chicken embryo. Int J Dev Biol. 2018;62:97–107.
Kuratani S. The neural crest origin in the neurocranium in vertebrates. Genesis. 2018;56(6–7):e23213.
Kuratani S, Kusakabe R, Hirasawa T. The neural crest and evolution of the head/trunk interface in vertebrates. Dev Biol. 2018;444(Suppl 1):S60–6.
Dworkin S, Boglev Y, Owens H, Goldie SJ. The role of sonic Hedgehog in craniofacial patterning, morphogenesis and cranial neural crest survival. J Dev Biol. 2016;4(3):24. https://doi.org/10.3390/jdb4030024.
He F, Chen Y. Wnt signaling in lip and palate development. Front Oral Biol. 2012;16:81–90.
Chai Y, Maxson RE. Recent advances in craniofacial morphogenesis. Dev Dyn. 2006;235:2353–75.
Johnston MC, Bronsky PT. Prenatal craniofacial development: new insights on normal and abnormal mechanisms. Crit Rev Oral Biol Med. 1995;6:368–422.
Moore KL, Persaud TVN, Torchia MG, editors. The developing human: clinically oriented embryology. 10th ed. Philadelphia: Elsevier; 2015. p. 155–93.
Nagarajan M, Sharbidre KG, Bhabad SH, Byrd SE. MR imaging of the fetal face: comprehensive review. Radiographics. 2018;38(3):962–80.
Som PM, Naidich TP. Illustrated review of the embryology and development of the facial region, part 1: early face and lateral nasal cavities. AJNR Am J Neuroradiol. 2013;34(12):2233–40.
Som PM, Naidich TP. Illustrated review of the embryology and development of the facial region, part 2: late development of the fetal face and changes in the face from the newborn to adulthood. AJNR Am J Neuroradiol. 2014;35(1):10–8.
Kurosaka H. The roles of Hedgehog signaling in upper lip formation. Biomed Res Int. 2015;2015:901041. https://doi.org/10.1155/2015/901041.
Sperber GH, Sperber SM, Gutmann GD. In: Shelto CT, editor. Craniofacial embryogenetics and development. 2nd edn. People Publishing Medical House; 2010, pp 37–60; 131–144.
Tan TY, Kilpatrick N, Farlie PG. Developmental and genetic perspectives on Pierre Robin sequence. Am J Med Genet C Semin Med Genet. 2013;163C(4):295–305.
Purnell CA, Janes LE, Klosowiak JL, Gosain AK. Mandibular catch-up growth in Pierre Robin sequence: a systematic review. Cleft Palate Craniofac J. 2018;1055665618774025. https://doi.org/10.1177/1055665618774025.
Bush JO, Jiang R. Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development. 2012;139(2):231–43.
Smarius B, Loozen C, Manten W, Bekker M, Pistorius L, Breugem C. Accurate diagnosis of prenatal cleft lip/palate by understanding the embryology. World J Methodol. 2017;7(3):93–100.
Kousa YA, Schutte BC. Toward an orofacial gene regulatory network. Dev Dyn. 2016;245(3):220–32.
Weng M, Chen Z, Xiao Q, Li R, Chen Z. A review of FGF signaling in palate development. Biomed Pharmacother. 2018;103:240–7.
Jones KL, editor. Smith’s recognizable patterns of human malformations. 4th ed. Philadelphia: Saunders Company Publishers; 1988. p. 662–706.
Cohen MM Jr. Syndromology: an updated conceptual overview: IX: facial dysmorphology. Int J oral Maxilofac Surg. 1990;19:81–8.
Hammond P. The use of 3D face shape modelling in dysmorphology. Arch Dis Child. 2007;92:1120–6.
Kirby RS. The prevalence of selected major birth defects in the United States. Semin Perinatol. 2017;41(6):338–44.
Caron CJJM, Pluijmers BI, Wolvius EB, Looman CWN, Bulstrode N, Evans RD, et al. Craniofacial and extra-craniofacial anomalies in craniofacial microsomia: a multicenter study of 755 patients. J Craniomaxillofac Surg. 2017;45(8):1302–10.
Heike CL, Wallace E, Speltz ML, Siebold B, Werler MM, Hing AV, et al. Characterizing facial features in individuals with craniofacial microsomia: a systematic approach for clinical research. Birth Defects Res A Clin Mol Teratol. 2016;106(11):915–26.
Birgfeld CB, Heike CL, Saltzman BS, Leroux BG, Evans KN, Luquetti DV. Reliable classification of facial phenotypic variation in craniofacial microsomia: a comparison of physical exam and photographs. Head Face Med. 2016;12:14. https://doi.org/10.1186/s13005-016-0109-x.
Brandstetter KA, Patel KG. Craniofacial microsomia. Facial Plast Surg Clin N Am. 2016;24:495–515.
Tuin AJ, Tahiri Y, Paine KM, et al. Clarifying the relationships among the different features of the OMENS1 classification in craniofacial microsomia. Plast Reconstr Surg. 2015;135(1):149e–56e.
Renkema RW, Caron CJJM, Wolvius EB, Dunaway DJ, Forrest CR, Padwa BL, Koudstaal MJ. Central nervous system anomalies in craniofacial microsomia: a systematic review. Int J Oral Maxillofac Surg. 2018;47(1):27–34.
Merritt L. Part 1. Understanding the embryology and genetics of cleft lip and palate. Adv Neonatal Care. 2005;5(2):64–71.
Shkoukani MA, Chen M, Vong A. Cleft lip—a comprehensive review. Front Pediatr. 2013;1:53.
Bernheim N, Georges M, Malevez C, De Mey A, Mansbach A. Embryology and epidemiology of cleft lip and palate. B-ENT. 2006;2 Suppl 4:11–9.
Menezes C, de Arruda JA, Silva LV, Monteiro JL, Caribé P, Álvares P, et al. Nonsyndromic cleft lip and/or palate: a multicenter study of the dental anomalies involved. J Clin Exp Dent. 2018;10(8):e746–50.
Sainsbury DCG, Davies A, Wren Y, Southby L, Chadha A, Slator R, Stock NM. The cleft multidisciplinary collaborative: establishing a network to support cleft lip and palate research in the United Kingdom. Cleft Palate Craniofac J. 2018:1055665618790174. https://doi.org/10.1177/1055665618790174.
Shkoukani MA, Lawrence LA, Liebertz DJ, Svider PF. Cleft palate: a clinical review. Birth Defects Res C Embryo Today. 2014;102(4):333–42.
Burg ML, Chai Y, Yao CA, Magee W 3rd, Figueiredo JC. Epidemiology, etiology and treatment of isolated cleft palate. Front Physiol. 2016;7:67. https://doi.org/10.3389/fphys.2016.00067.
Hyoun SC, Obican SG, Scially AR. Teratogen update: methotrexate. Birth Defects Res A. 2012;94:187–207.
Del Campo M, Kosaki K, Bennett FC, Jones KL. Developmental delay in fetal aminopterin/methotrexate syndrome. Teratology. 1999;60:10–2.
www.reprotox. Methotrexate. Updated: August22, 2018.
Sulik KK, Cook CS, Webster WS. Teratogens and craniofacial malformations: relationship to cell death. Development. 1988;103(Suppl):213–31.
Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N, on behalf of the Network of French Pharmacovigilance Centers, et al. Pregnancy outcome after rheumatologic methotrexate (MTX) treatment prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014;66(5):1101–110.
www.reprptox. Isotretinoin. Updated 27.9.2018.
Benke PJ. The isotretinoin teratogen syndrome. J Am Med Assoc. 1984;251:3267–9.
Braun JT, Franciosi RA, Mastri AR, Drake RM, O’Neil BL. Isotretinoin dysmorphic syndrome. Lancet. 1984;1:506–7.
Jahn AF, Ganti K. Major auricular malformations due to Accutane (isotretinoin). Laryngoscope. 1987;97(7 Pt 1):832–5.
Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837–41.
Adams J. The neurobehavioral teratology of retinoids: a 50-year history. Birth Defects Res A Clin Mol Teratol. 2010;88(10):895–905.
www.reprotox. Cyclophosphamide. Updated 29.9.2018.
Kirshon B, et al. Teratogenic effects of first trimester cyclophosphamide therapy. Obstet Gynecol. 1988;72:462.
Zemlickis D, Lishner M, Erlich R, Koren G. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen. 1993;13:139–43.
Vaux KK, Kahole N, Jones KL. Pattern of malformation secondary to prenatal exposure to cyclophosphamide (abstract). Teratology. 2002;65:297.
Rengasamy P. Congenital malformations attributed to prenatal exposure to cyclophosphamide. Am J Med Genet. 1999;86(3):237–41.
Leyder M, Laubach M, Breugelmans M, et al. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy. Gynecol Obstet Invest. 2011;71(2):141–4.
Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, Cox VA, Golabi M. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Anti Cancer Agents Med Chem. 2017;17(9):1211–27.
Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf. 1998;19(5):389–410.
www.reprotox. Mycophenolate mofetil. Updated 27.7. 2018.
Perez-Aytes A, Ledo A, Boso V, Sáenz P, Roma E, Poveda JL, Vento M. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A. 2008;146A(1):1–7.
Merlob P, Stahl B, Klinger G. Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol. 2009;28(1):105–8.
Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Doria C, McGrory CH, Armenti VT. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. In: Cecka JM, Terasaki PI, editors. Clinical transplants. Los Angeles, CA: Terasaki Foundation Laboratory; 2008. p. 91–107.
Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet. 2012;158A:588–96.
www.reprotox. Valproic acid. Updated 12.2018.
Kozma C. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet. 2001;98(2):168–75.
Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? A review. Reprod Toxicol. 2009;28:1–10.
Bromfield BE, Dworetzky BA, Wyszynski DF, Smith CR, Baldwin EJ, Holmes LB. Valproate teratogenicity and epilepsy syndrome. Epilepsia. 2008;49:1122–4.
Ornoy A, Arnon J, Shechtman S, Diav-Citrin O. The developmental effects of maternal antiepileptic drugs with special emphasis on carbamazepine. Reprod Toxicol. 2004;19:248–9.
Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child. 1996;75:515–20.
Kelly TE. Teratogenicity of antiepileptic drugs. Review of the literature. Am J Med Genet. 1984;19:413–34.
www.reprotox. Alcohol, ethyl. Updated 6.7. 2018.
Clarren SK. Recognition of fetal alcohol syndrome. JAMA. 1981;245:2436–9.
Senturias Y, Asamoah A. Fetal alcohol spectrum disorders: guidance for recognition, diagnosis, differential diagnosis and referral. Curr Probl Pediatr Adolesc Health Care. 2014;44(4):88–95.
Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, Frias JL. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. Birth Defects Res A. 2004;70:194–200.
Smith SM, Garic A, Flentke GR, Berres ME. Neural crest development in fetal alcohol syndrome. Birth Defects Res C Embryo Today. 2014;102(3):210–20.
Liyanage VR, Curtis K, Zachariah RM, Chudley AE, Rastegar M. Overview of the genetic basis and epigenetic mechanisms that contribute to FASD pathobiology. Curr Top Med Chem. 2017;17(7):808–28.
Chater-Diehl EJ, Laufer BI, Singh SM. Changes to histone modifications following prenatal alcohol exposure: an emerging picture. Alcohol. 2017;60:41–52.
www.reprotox. Cigarette smoking. Updated 23.8.2018.
Xuan Z, Zhongpeng Y, Yanjun G, Jiaqi D, Yuchi Z, Bing S, Chenghao L. Maternal active smoking and risk of oral clefts: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(6):680–90.
Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2003;25(4):427–36.
Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA. Maternal smoking and congenital heart defects. Pediatrics. 2008;121:e810–6.
Garrocho-Rangel A, Manriquez-Olmos L, Flores-Velazquez J, Rosales-Berber MA, Martinez-Rider R, Pozos-Guillen A. Non-syndromic craniosynostosis in children: scoping review. Med Oral Patol Oral Cir Bucal. 2018;23(4):e421–8.
Kutkowska-Kaźmierczak A, Gos M, Obersztyn E. Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling. J Appl Genet. 2018;59(2):133–47.
Ko JM. Genetic syndromes associated with craniosynostosis. J Korean Neurosurg Soc. 2016;59(3):187–91.
Shim KW, Park EK, Kim JS, Kim YO, Kim DS. Neurodevelopmental problems in non-syndromic craniosynostosis. J Korean Neurosurg Soc. 2016;59(3):242–6.
Shim KW, Lee MJ, Lee MC, Park EK, Kim DS, Hong H, Kim YO. Computer-assisted shape descriptors for skull morphology in craniosynostosis. Childs Nerv Syst. 2016;32(3):511–7.
Buchanan EP, Xue Y, Xue AS, Olshinka A, Lam S. Multidisciplinary care of craniosynostosis. J Multidiscip Healthc. 2017;10:263–70.
Liu C, Cui Y, Luan J, Zhou X, Han J. The molecular and cellular basis of Apert syndrome. Intractable Rare Dis Res. 2013;2(4):115–22.
Das S, Munshi A. Research advances in Apert syndrome. J Oral Biol Craniofac Res. 2018;8(3):194–9.
Al-Namnam NM, Hariri F, Thong MK, Rahman ZA. Crouzon syndrome: genetic and intervention review. J Oral Biol Craniofac Res. 2019;9(1):37–9.
Giancotti A, D’Ambrosio V, Marchionni E, Squarcella A, Aliberti C, La Torre R, et al. Pfeiffer syndrome: literature review of prenatal sonographic findings and genetic diagnosis. J Matern Fetal Neonatal Med. 2017;30(18):2225–31.
Williamson I, Arlt W, Shakleton C, Kelley RI, Braddock SR. Linking Antley-Bixler syndrome and congenital adrenal hyperplasia; a novel case of p450 oxidoreductase deficiency. Am J Med Genet A. 2006;140A:1797–803.
Oldani E, Garel C, Bucourt M, Carbillon L. Prenatal diagnosis of Antley-Bixler syndrome and POR deficiency. Am J Case Rep. 2015;16:882–5.
Reardon W, Winter RM. Saethre-Chotzen syndrome. J Med Genet. 1994;31(5):393–6.
Cai J, Goodman BK, Patel AS, Mulliken JB, Van Maldergem L, Hoganson GE, et al. Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet. 2003;114(1):68–76.
Doherty ES, Lacbawan F, Hadley DW, Brewer C, Zalewski C, Kim HJ, et al. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A. 2007;143A(24):3204–15.
Grutzner E, Gorlin RJ. Craniofrontonasal dysplasia: phenotypic expression in females and males and genetic considerations. Oral Surg Oral Med Oral Pathol. 1988;65(4):436–44.
Johnson D, Wilkie AO. Craniosynostosis. Eur J Hum Genet. 2011;19(4):369–76.
Tahiri Y, Bartlett SP, Gilardino MS. Evidence-based medicine: nonsyndromic craniosynostosis. Plast Reconstr Surg. 2017;140(1):177e–91e.
Lan Y, Jia S, Jiang R. Molecular patterning of the mammalian dentition. Semin Cell Dev Biol. 2014;25–26:61–70.
Hovorakova M, Lesot H, Peterka M, Peterkova R. Early development of the human dentition revisited. J Anat. 2018;233:135–45.
Sharpe PT. Neural crest and tooth morphogenesis. Adv Dent Res. 2001;15:4–7.
Seppala M, Fraser GJ, Birjandi AA, Xavier GM, Cobourne MT. Sonic Hedgehog signaling and development of the dentition. J Dev Biol. 2017;5(2):6. https://doi.org/10.3390/jdb5020006.
Xavier GM, Seppala M, Barrell W, Birjandi AA, Geoghegan F, Cobourne MT. Hedgehog receptor function during craniofacial development. Dev Biol. 2016;415(2):198–215.
Cobourne MT, Sharpe PT. Diseases of the tooth: the genetic and molecular basis of inherited anomalies affecting the dentition. Wiley Interdiscip Rev Dev Biol. 2013;2(2):183–212.
Klein OD, Oberoi S, Huysseune A, Hovorakova M, Peterka M, Peterkova R. Developmental disorders of the dentition: an update. Am J Med Genet C Semin Med Genet. 2013;163C(4):318–32.
Menezes C, de Arruda JA, Silva LV, Monteiro JL, Caribé P, Álvares P, Almeida MC, Coelli JC, Goldemberg F, Silveira M, Sobral AP, Bueno DF. Nonsyndromic cleft lip and/or palate: a multicenter study of the dental anomalies involved. J Clin Exp Dent. 2018;10(8):e746–50.
Conflict of Interest Statement
The author declares that he has no conflict of interest. This review was not supported by any specific research grant.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ornoy, A. (2021). The Developmental Interrelation Between the Nervous System and Craniofacial Complex as Evidenced from Craniofacial Malformations. In: Meyer, U. (eds) Fundamentals of Craniofacial Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-46024-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-46024-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46023-5
Online ISBN: 978-3-030-46024-2
eBook Packages: MedicineMedicine (R0)